1. Medtech Insight

Neuro Panel Takeaways: Detailed Responses On Aneurysm Devices From US FDA Advisors

Point-by-point clinical trial recommendations from US FDA's Neurological Devices Advisory Panel at a recent meeting on intracranial aneurysm devices.

FDA Advisory Committee Feature image

US FDA's Neurological Devices Advisory Panel convened March 1 in Gaithersburg, Md., to discuss and give recommendations to the agency on what should be required of sponsors when conducting clinical trials for intracranial aneurysm devices and making product submissions. Also see "Brain Trust Advises US FDA On Aneurysm Device Trials" - Medtech Insight, 2 March, 2018.

At the end of the meeting, Christopher Loftus, chief medical officer in the Division of Neurological and Physical Medicine Devices...

More from Neurology

More from Device Area

Corify Care, Mayo Clinic Join Forces To Advance AI-Driven Global Cardiac Mapping Platform

 
• By Shubham Singh

Corify Care’s CEO said the company aims to submit its 510(k) application to the US FDA by year-end, targeting market clearance in 2026. The company hopes its collaboration with the Mayo Clinic will help speed adoption of ACORYS, a noninvasive mapping technology for use in complex cardiac ablations.

Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations

 
• By Vibha Sharma

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.

Former Top OIG Attorney Gives Inside Look At Fraud Prevention

 
• By Elizabeth Orr

Former HHS-OIG attorney Rob DeConti emphasized the significance of data analytics and compliance in combating healthcare fraud, urging medical tech companies to adopt robust measures to prevent potential risks.